7Mc Gregor D, Shand B, Lynn K. A controlled trial of the effect of folate supplements on homocysteine, lipids and hemorheology in end-stage renal disease. Nephron, 2000, 85(3) :215--20.
3Uyemura K,Demer LL,Castle SC,et al.Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis[].The Journal of Clinical Investigation.1996
4Roselaar SE,Nazhat NB,Winyard PG,et al.Detection of oxidants in uremic plasma by electron spin resonance spectroscopy[].Kidney International.1995
5Joven J,Vilella E,Ahmed S,et al.Lipoprotein heterogeneity in end stage renal disease[].Kidney International.1993
6Chauveau P,Chadefaux B,Coude M,et al.Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients[].Kidney International Supplement.1993
7Nilsson J.Cytokines and smooth muscle in atherosclerosis[].Cardiovascular Research.1993
8Perna AF,Ingrosso D,De Santo NG,et al.Metabolic consequences of folate-induced reduction of hyperhomocysteinemia in uremia[].Journal of the American Society of Nephrology.1997
9Vallance P,Leone A,Calver A,et al.Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure[].The Lancet.1992
10Giardino I,Edelstein D,Brownlee M.BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advances glycation endproducts in bovine endothelial cells[].The Journal of Clinical Investigation.1996
3Samuelsson O, Attman PO, Knight-Gibson C, et al. Complex apolipoprotein B-containing llpoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency [ J ]. J Am Soc Nephrol, 1998,9:1482-1488.
4Avram MM. Similarities between glomerular sclerosis and atheroselerosis in human renal biopsy specimens : a role for lipopretein glomerulopathy [J]. Am J Med,1989,87(SN) :39N-41N.
5Weinbcrg JM. Hpotoxicity[J]. Kideny Int, 2006,70 : 1560-1563.
6Megergor D, Shand B, Lynn K. A controlled trial of the effect of folate supplements on homocysteine, lipids and hemorheology in end-stage renal disease[J]. Nephron,2000,85(3) :215-250.
7Marfella R, D'Amico M, Di Filippo C, et al. The possible role of the ubiquitin proteasome system in the development of atherosclerosis in diabetes[ J]. Cardiovase Diabetol,2007 ,6 :35-37.
8Kirig DA, Codish S, Novach V, et al. The role of cardiac troponin Ⅰ as a prognosticator in critically ill medical patients : a prospective observational cohort study[J]. Crit Care Med, 2005,9 (4) :R390-R395.
9Saito Y, Nakao M, MaKoyana M, et al.Increase plasma endothelin level in patients with essential hypertension[J]. N Engl Med J, 1990,322:205-208.
